167 related articles for article (PubMed ID: 30811628)
1. Synthetic Cannabinoid-Associated Multiple Organ Failure: Case Series and Literature Review.
Armstrong F; McCurdy MT; Heavner MS
Pharmacotherapy; 2019 Apr; 39(4):508-513. PubMed ID: 30811628
[TBL] [Abstract][Full Text] [Related]
2. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
[TBL] [Abstract][Full Text] [Related]
3. Altered mental status and end organ damage associated with the use of gacyclidine: a case series.
Chenoweth JA; Gerona RR; Ford JB; Sutter ME; Rose JS; Albertson TE; Clarke SO; Owen KP
J Med Toxicol; 2015 Mar; 11(1):115-20. PubMed ID: 25048606
[TBL] [Abstract][Full Text] [Related]
4. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal.
Cooper ZD
Curr Psychiatry Rep; 2016 May; 18(5):52. PubMed ID: 27074934
[TBL] [Abstract][Full Text] [Related]
5. Multiple organ dysfunction syndrome, an unusual complication of heroin intoxication: a case report and review of literature.
Feng G; Luo Q; Guo E; Yao Y; Yang F; Zhang B; Li L
Int J Clin Exp Pathol; 2015; 8(9):11826-30. PubMed ID: 26617935
[TBL] [Abstract][Full Text] [Related]
6. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
[TBL] [Abstract][Full Text] [Related]
7. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure.
Argamany JR; Reveles KR; Duhon B
Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191
[TBL] [Abstract][Full Text] [Related]
8. K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.
McKeever RG; Vearrier D; Jacobs D; LaSala G; Okaneku J; Greenberg MI
J Med Toxicol; 2015 Mar; 11(1):129-31. PubMed ID: 25154434
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
10. Combined organ failure with combination antihyperlipidemic treatment: a case of hepatic injury and acute renal failure.
Akoglu H; Yilmaz R; Kirkpantur A; Arici M; Altun B; Turgan C
Ann Pharmacother; 2007 Jan; 41(1):143-7. PubMed ID: 17148651
[TBL] [Abstract][Full Text] [Related]
11. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
[TBL] [Abstract][Full Text] [Related]
12. Rapidly reversible multiorgan failure after ingestion of "Molly" (pure 3,4-methylenedioxymethamphetamine): a case report.
Vakde T; Diaz M; Uday K; Duncalf R
J Med Case Rep; 2014 Jun; 8():204. PubMed ID: 24942782
[TBL] [Abstract][Full Text] [Related]
13. [Acute rhabdomyolysis: a case report and literature review].
Mrsić V; Nesek Adam V; Grizelj Stojcić E; Rasić Z; Smiljanić A; Turcić I
Acta Med Croatica; 2008 Jul; 62(3):317-22. PubMed ID: 18843854
[TBL] [Abstract][Full Text] [Related]
14. Acute intoxication caused by three common synthetic cannabinoids: The experience of a large, urban, tertiary care hospital.
Shopan N; Scolnik D; Hassoun E; Firsow A; Volkov I; Glatstein M
Am J Emerg Med; 2023 Nov; 73():7-10. PubMed ID: 37572408
[TBL] [Abstract][Full Text] [Related]
15. Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high.
Sherpa D; Paudel BM; Subedi BH; Chow RD
J Community Hosp Intern Med Perspect; 2015; 5(4):27540. PubMed ID: 26333853
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.
Monte AA; Calello DP; Gerona RR; Hamad E; Campleman SL; Brent J; Wax P; Carlson RG;
J Med Toxicol; 2017 Jun; 13(2):146-152. PubMed ID: 28397128
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort.
Brandehoff N; Adams A; McDaniel K; Banister SD; Gerona R; Monte AA
Clin Toxicol (Phila); 2018 Mar; 56(3):193-198. PubMed ID: 28862050
[TBL] [Abstract][Full Text] [Related]
18. MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.
Novelli G; Rossi M; Pretagostini R; Poli L; Novelli L; Berloco P; Ferretti G; Iappelli M; Cortesini R
Liver; 2002; 22 Suppl 2():43-7. PubMed ID: 12220303
[TBL] [Abstract][Full Text] [Related]
19. A Rare Case of Methamphetamine-Induced Severe Rhabdomyolysis and Compartment Syndrome.
Hajnoczky N; George D
Cureus; 2023 May; 15(5):e39804. PubMed ID: 37398711
[TBL] [Abstract][Full Text] [Related]
20. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
